Free Trial

Franklin Genomic Advancements ETF (HELX) Institutional Ownership

$33.63 -0.10 (-0.30%)
As of 05/8/2026 04:10 PM Eastern

Institutional Ownership Changes (13F Filings) for Franklin Genomic Advancements ETF (BATS:HELX)

Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$168.26K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$893.09K
Get HELX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Franklin Genomic Advancements ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

HELX Institutional Buying and Selling by Quarter

Franklin Genomic Advancements ETF Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2026 Kestra Advisory Services LLC1,069$39K0.0%N/A0.267%
2/11/2026 LPL Financial LLC11,133$404K0.0%+22.4%2.783%
9/4/2025Osaic Holdings Inc.3,132$87K0.0%+19.1%0.783%
8/14/2025Raymond James Financial Inc.1,500$42K0.0%N/A0.375%
5/19/2025Jane Street Group LLC8,049$217K0.0%-80.4%2.012%
5/8/2025Harbour Investments Inc.1,823$49K0.0%+1,240.4%0.456%
4/18/2025Halbert Hargrove Global Advisors LLC2,554$69K0.0%+41.8%0.639%
2/17/2025Citadel Advisors LLC7,966$230K0.0%N/A2.655%
2/14/2025Jane Street Group LLC41,030$1.18M0.0%N/A13.677%
2/11/2025LPL Financial LLC16,965$489K0.0%+19.5%5.655%
2/5/2025Halbert Hargrove Global Advisors LLC1,801$52K0.0%N/A0.600%
7/31/2024Commonwealth Equity Services LLC6,677$212K0.0%-5.2%2.226%
1/26/2023Vigilant Capital Management LLC900$27K0.0%N/A0.000%


HELX Institutional Ownership - Frequently Asked Questions

During the previous two years, 9 institutional investors and hedge funds held shares of Franklin Genomic Advancements ETF. The most heavily invested institutionals were LPL Financial LLC ($404K), Citadel Advisors LLC ($230K), Jane Street Group LLC ($217K), Commonwealth Equity Services LLC ($212K), Osaic Holdings Inc. ($87K), Halbert Hargrove Global Advisors LLC ($69K), and Harbour Investments Inc. ($49K).Learn more on Franklin Genomic Advancements ETF's institutional investors.

The following institutional investors have purchased Franklin Genomic Advancements ETF's stock in the last 24 months: Jane Street Group LLC ($41.03K), Citadel Advisors LLC ($7.97K), LPL Financial LLC ($4.81K), Halbert Hargrove Global Advisors LLC ($2.55K), Harbour Investments Inc. ($1.69K), Raymond James Financial Inc. ($1.50K), and Kestra Advisory Services LLC ($1.07K).

Institutional investors have bought a total of 5,108 shares in the last 24 months. This purchase volume represents approximately $168.26K in transactions.

The following institutional investors have sold Franklin Genomic Advancements ETF stock in the last 24 months: Jane Street Group LLC ($32.98K).

Institutional investors have sold a total of 32,981 shares in the last 24 months. This volume of shares sold represents approximately $893.09K in transactions.



This page (BATS:HELX) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners